MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development

The expression of microRNAs is altered in various cancer types, leading to their definition as onco‐ and tumor‐suppressor microRNAs. In our study, we investigated the role of miR‐335 in the formation of sporadic human breast cancer and its involvement in the regulatory network of the breast cancer susceptibility gene BRCA1. To validate single components of the BRCA1 cascade, microRNA overexpression was performed in a cell culture model with subsequent protein analysis and luciferase reporter assays. Here, we were able to identify miR‐335 as simultaneously regulating the known BRCA1 activators ERα, IGF1R, SP1 and the repressor ID4, including a feedback regulation of miR‐335 expression by estrogens. Overexpression of miR‐335 resulted in an upregulation of BRCA1 mRNA expression, suggesting a functional dominance of ID4 signaling. The relevance of the miR‐335 regulation for human breast cancer was confirmed in primary sporadic breast cancer specimens with significantly decreased miR‐335 levels (p < 0.05) in comparison to normal controls. Interestingly, the microRNA expression level correlated positively to the BRCA1 transcript level, supporting the hypothesis of a miR‐335‐mediated regulation of the tumor suppressor gene. Functionally, overexpression of miR‐335 led to decreased cell viability and an increase in apoptosis, supporting its tumor‐suppressive function. In summary, our data indicate that miR‐335 affects different targets in the upstream BRCA1‐regulatory cascade with impact on key cellular functions such as proliferation and apoptosis. Deregulation of the microRNA during breast cancer development and progression may thereby lead to an increased tumorigenic potential by inactivating crucial tumor‐suppressive signals.

[1]  Ji Wan,et al.  Structure and activity of putative intronic miRNA promoters. , 2010, RNA.

[2]  Michael P. DiGiovanna,et al.  Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines , 2010, Breast Cancer Research and Treatment.

[3]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[4]  C. Klinge.  Estrogen Regulation of MicroRNA Expression , 2009, Current genomics.

[5]  Ding‐Shinn Chen,et al.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. , 2009, Gastroenterology.

[6]  N. Kondo,et al.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. , 2009, Cancer research.

[7]  A. Addario,et al.  Role of microRNAs in drug-resistant ovarian cancer cells. , 2008, Gynecologic oncology.

[8]  Domenico Coppola,et al.  MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.

[9]  K. Coombes,et al.  Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells , 2008, Molecular Cancer Therapeutics.

[10]  A. Chakraborty,et al.  Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer. , 2008, Cancer research.

[11]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[12]  M. Q. Kemp,et al.  Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene , 2008, Breast Cancer Research.

[13]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[14]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[15]  R. Miranda,et al.  Competing Interactions between Micro-RNAs Determine Neural Progenitor Survival and Proliferation after Ethanol Exposure: Evidence from an Ex Vivo Model of the Fetal Cerebral Cortical Neuroepithelium , 2007, The Journal of Neuroscience.

[16]  B. White,et al.  The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines , 2007 .

[17]  A. Ashworth,et al.  BRCA1 dysfunction in sporadic basal-like breast cancer , 2007, Oncogene.

[18]  R. Yarden,et al.  Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1. , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[19]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[20]  B. White,et al.  The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. , 2007, Molecular endocrinology.

[21]  C. Moskaluk,et al.  Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells , 2006, Oncogene.

[22]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[23]  G. Roldan,et al.  Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer , 2006, Cancer biology & therapy.

[24]  M. Q. Kemp,et al.  The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. , 2006, Cancer research.

[25]  B. Jeffy,et al.  An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. , 2005, Neoplasia.

[26]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[27]  Q. Su,et al.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.

[28]  C. Qiu,et al.  Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas. , 2003, The American journal of pathology.

[29]  P. J. Welch,et al.  Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. D'aiuto,et al.  Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. , 2000, Cancer research.

[31]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[32]  M. Rubini,et al.  The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. , 1997, Experimental cell research.

[33]  J Benichou,et al.  Proportion of breast cancer cases in the United States explained by well-established risk factors. , 1995, Journal of the National Cancer Institute.

[34]  David L. Page,et al.  Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.

[35]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[36]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[37]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[38]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.